Verve Therapeutics, Inc. sold Verve Therapeutics, Inc. to Eli Lilly and Company as part of a acquisition on 2025-06-17.
Deal value was 10000000000 (source: Extracted) Seller position: 100% acquisition; Sector: Healthcare; Location: USA.
On the seller side, Paul, Weiss advised, led by Krishna Veeraraghavan, Benjamin Goodchild.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Kirkland & Ellis advises Eli Lilly on its $1.3 billion acquisition of Verve Therapeutics, with Paul, Weiss advising Verve Therapeutics. | The Sponsor - The Sponsor
